These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6609128)

  • 1. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b.
    Steele NP; Munson RS; Granoff DM; Cummins JE; Levine RP
    Infect Immun; 1984 May; 44(2):452-8. PubMed ID: 6609128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK; Johnson RC
    Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b.
    Amir J; Scott MG; Nahm MH; Granoff DM
    J Infect Dis; 1990 Jul; 162(1):163-71. PubMed ID: 2355193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation.
    Jarvis GA; Vedros NA
    Infect Immun; 1987 Jan; 55(1):174-80. PubMed ID: 3098684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.
    Selander B; Käyhty H; Wedege E; Holmström E; Truedsson L; Söderström C; Sjöholm AG
    J Clin Immunol; 2000 Mar; 20(2):138-49. PubMed ID: 10821465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activity against Haemophilus influenzae.
    Gordon DL
    Pathology; 1988 Apr; 20(2):124-9. PubMed ID: 3264903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.
    Jönsson G; Hansson C; Mellhammar L; Gullstrand B; Bengtsson AA; Sahl C; Skattum L
    Vaccine; 2021 Feb; 39(8):1297-1302. PubMed ID: 33509693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased protective efficacy of reduced and alkylated human immune serum globulin in experimental infection with Haemophilus influenzae type b.
    Schreiber JR; Barrus VA; Siber GR
    Infect Immun; 1985 Jan; 47(1):142-8. PubMed ID: 3871195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE; Pelton SI; Gulati S; Rice PA
    J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of complement depletion on anticapsular-antibody-mediated immunity to experimental infection with Haemophilus influenzae type b.
    Schreiber JR; Basker CJ; Siber GR
    Infect Immun; 1987 Nov; 55(11):2830-3. PubMed ID: 3499398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.
    Rosadini CV; Ram S; Akerley BJ
    Infect Immun; 2014 Feb; 82(2):640-9. PubMed ID: 24478079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lipopolysaccharide phase variation in susceptibility of Haemophilus influenzae to bactericidal immunoglobulin M antibodies in rabbit sera.
    Erwin AL; Brewah YA; Couchenour DA; Barren PR; Burke SJ; Choi GH; Lathigra R; Hanson MS; Weiser JN
    Infect Immun; 2000 May; 68(5):2804-7. PubMed ID: 10768976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b.
    Schreiber JR; Barrus V; Cates KL; Siber GR
    J Infect Dis; 1986 Jan; 153(1):8-16. PubMed ID: 3484506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia.
    Brown EJ; Hosea SW; Hammer CH; Burch CG; Frank MM
    J Clin Invest; 1982 Jan; 69(1):85-98. PubMed ID: 7054244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement in the host's defense against Haemophilus influenzae.
    Winkelstein JA; Moxon ER
    J Infect Dis; 1992 Jun; 165 Suppl 1():S62-5. PubMed ID: 1588179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
    Des Prez RM; Bryan CS; Hawiger J; Colley DG
    Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.
    Hetherington SV
    Immunology; 1989 May; 67(1):87-91. PubMed ID: 2786843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
    Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.